Eden Research (LON:EDEN) Shares Down 8.3% – Should You Sell?

Eden Research plc (LON:EDEN)’s share price fell 8.3% on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.30 ($0.04). 280,171 shares changed hands during trading, a decline of 70% from the average session volume of 928,276 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 8.3 %

The firm has a market capitalization of £17.60 million, a price-to-earnings ratio of -11.56 and a beta of 0.92. The company has a fifty day moving average price of GBX 3.88 and a two-hundred day moving average price of GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Transactions at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.